Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20508,836,0.98 [0.82-1.18],0.8469316675962959
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20467,164,0.82 [0.52-1.29],0.3928626569114402
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22132,161,0.73 [0.45-1.17],0.1884690836024534
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15599,629,1.07 [0.87-1.32],0.5217913140907531
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22076,105,0.65 [0.35-1.20],0.1708704284985778
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21213,76,0.77 [0.39-1.51],0.4406604594583423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23255,104,0.64 [0.34-1.19],0.1601938256554538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23249,69,0.67 [0.32-1.43],0.3031203169183343
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20672,49,1.61 [0.97-2.67],0.0669207004452492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22719,104,0.95 [0.56-1.60],0.8511922905260654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22680,65,0.64 [0.29-1.39],0.2552695165150304
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23318,67,1.20 [0.69-2.10],0.5220658674241878
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23294,85,1.23 [0.75-2.02],0.4169053230227164
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23291,82,1.24 [0.75-2.04],0.3976177314451582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,22999,58,1.09 [0.57-2.10],0.7958884550951134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22326,359,0.96 [0.72-1.27],0.7573270076201504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22080,113,0.63 [0.35-1.14],0.1298284071942617
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22215,248,0.95 [0.68-1.33],0.7627049905653578
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19083,44,0.92 [0.40-2.09],0.8354245726254075
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19093,54,0.91 [0.44-1.89],0.8026355453516623
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19260,221,0.96 [0.67-1.38],0.8424139506248178
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19267,228,0.99 [0.70-1.41],0.9758315597359776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19609,570,0.98 [0.78-1.22],0.8365322704840876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19086,47,1.10 [0.53-2.27],0.8068208557472685
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20936,868,0.92 [0.77-1.11],0.3893590666908483
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22429,253,1.09 [0.80-1.49],0.5863107190042318
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23030,100,1.60 [1.12-2.28],0.0094647613674724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23401,80,0.79 [0.41-1.52],0.4739267081172091
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23220,54,1.05 [0.53-2.09],0.8786078304708069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,0.62 [0.27-1.42],0.2565255748899778
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Stomach,23444,44,0.48 [0.17-1.33],0.157521046764083
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23257,243,0.83 [0.58-1.20],0.3229494384477329
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23399,99,0.79 [0.44-1.41],0.4224377908025308
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23400,92,0.74 [0.39-1.38],0.3402472778164809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23334,61,0.73 [0.34-1.58],0.4312761077208255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",23336,60,0.73 [0.34-1.59],0.4302867210168764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,23253,227,0.92 [0.65-1.32],0.6680388758462705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23402,107,1.11 [0.70-1.77],0.6484875255445586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,23308,193,0.71 [0.46-1.10],0.1217453257845455
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of breast,23388,120,1.03 [0.64-1.64],0.9134714827141844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Leiomyoma of uterus,22970,852,1.05 [0.88-1.25],0.5657254953172335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22289,230,0.91 [0.63-1.30],0.6020788307295151
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22052,377,1.03 [0.79-1.34],0.8341802225645256
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22052,377,1.03 [0.79-1.34],0.8341802225645256
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20756,333,0.82 [0.60-1.13],0.2307088594811037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22938,84,0.47 [0.22-0.98],0.0442860089076915
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23151,82,0.92 [0.50-1.69],0.7935548274780252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19446,750,0.99 [0.81-1.20],0.8992163426163575
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21500,747,0.87 [0.71-1.07],0.1935364940002598
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,21875,92,1.30 [0.83-2.02],0.2518948933464424
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22564,46,1.43 [0.79-2.58],0.2344229720847263
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21865,82,1.27 [0.79-2.05],0.3167683956434638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22127,344,1.13 [0.86-1.49],0.3726652271253398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22117,334,1.10 [0.83-1.46],0.4956969425868039
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21694,158,1.35 [0.91-2.02],0.1395882883722784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21696,155,1.36 [0.91-2.04],0.1360864633124055
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19280,584,1.01 [0.81-1.27],0.9072540744460246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18764,68,1.13 [0.63-2.00],0.683565915802917
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19240,544,1.00 [0.79-1.26],0.9891750343481138
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18741,45,0.96 [0.44-2.12],0.922856774313987
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18752,56,0.89 [0.42-1.86],0.7502165052672471
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,19793,506,0.90 [0.69-1.15],0.3924080175174458
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19384,97,1.09 [0.63-1.89],0.7652563068877787
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23233,63,1.14 [0.62-2.12],0.6707853544305671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23265,37,1.26 [0.59-2.66],0.5505079337966119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22218,32,1.12 [0.45-2.77],0.8119493485818386
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23402,32,1.07 [0.43-2.67],0.8846276034622838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19319,32,1.14 [0.45-2.84],0.7853396253047189
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Alcohol dependence,22208,22,1.27 [0.46-3.50],0.6390611239020721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,22125,30,0.88 [0.30-2.61],0.8130761771124986
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19325,38,1.07 [0.45-2.55],0.8726158726099787
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19595,308,0.96 [0.71-1.31],0.8151462034959844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression,21747,275,0.94 [0.67-1.30],0.6924291273490437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,19417,238,0.90 [0.62-1.29],0.5567056161388678
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19413,126,0.75 [0.44-1.28],0.285200508877826
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,21820,64,0.54 [0.24-1.22],0.1390658537567434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,20314,1386,1.00 [0.87-1.15],0.9875229092210128
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18584,161,0.97 [0.64-1.46],0.8746207833082201
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23274,131,0.95 [0.60-1.52],0.8425875776407911
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22338,362,1.01 [0.76-1.32],0.96944406554276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,22090,114,0.97 [0.59-1.59],0.90243476464855
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,22082,106,1.22 [0.79-1.88],0.3769041443782119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23064,98,1.24 [0.79-1.94],0.3498884333655957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22861,51,0.70 [0.30-1.64],0.4100371617443367
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22063,87,1.13 [0.67-1.89],0.6569266873362987
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23095,61,1.13 [0.61-2.10],0.7004380811783887
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22273,714,1.00 [0.82-1.21],0.9729090817673168
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21661,102,1.04 [0.63-1.72],0.8901766889551134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22012,453,1.00 [0.79-1.28],0.9755289211218776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23228,64,0.86 [0.43-1.72],0.669016874653964
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,23213,49,0.90 [0.42-1.95],0.7985849011411368
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23028,104,0.99 [0.60-1.65],0.9745653012543568
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22815,364,1.15 [0.90-1.48],0.2694318483379884
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22660,209,0.92 [0.63-1.34],0.6524999790508621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22513,62,1.64 [1.08-2.50],0.0205947016125132
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22563,112,0.90 [0.54-1.52],0.7055134005253962
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22542,91,1.30 [0.83-2.04],0.2595547234913163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19901,145,1.31 [0.91-1.89],0.1492856330918528
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20111,355,1.02 [0.77-1.35],0.9055815244368988
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22561,150,1.04 [0.69-1.57],0.8532056732307042
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23218,28,1.79 [0.99-3.26],0.0559535417284506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1500,28,1.96 [0.99-3.90],0.0543103806500202
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",21746,28,1.77 [0.97-3.21],0.0617495826593719
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22848,76,1.66 [1.12-2.44],0.0107970976379247
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22811,39,1.64 [0.96-2.81],0.0707472884644254
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22718,77,1.31 [0.81-2.13],0.2715166958476005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22939,89,1.28 [0.82-2.00],0.2842738759042811
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23335,106,1.34 [0.89-2.01],0.1584826096683046
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22777,93,1.14 [0.70-1.87],0.5936380266877538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17244,2351,0.96 [0.85-1.08],0.4834096111370388
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22962,66,1.13 [0.63-2.04],0.6890202927155087
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18142,1728,0.95 [0.83-1.09],0.4797131276519966
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,18157,1743,0.96 [0.83-1.10],0.536998181985451
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16446,32,1.41 [0.77-2.59],0.2653826634722477
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22031,602,0.99 [0.80-1.24],0.945651893779726
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,21848,419,1.10 [0.86-1.40],0.4631171730615638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22876,122,1.22 [0.81-1.84],0.3412529507533244
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22940,186,0.98 [0.66-1.45],0.9110513982517406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23381,24,0.23 [0.05-1.05],0.0574917357941002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21506,77,0.71 [0.35-1.43],0.3365908718173777
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21808,388,0.92 [0.69-1.22],0.5590727526964017
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22764,85,1.11 [0.65-1.88],0.7034092518591479
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22858,184,1.22 [0.88-1.71],0.2332521015055785
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22767,88,1.18 [0.72-1.94],0.5052810423410329
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22767,88,1.18 [0.72-1.94],0.5052810423410329
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16499,85,1.16 [0.71-1.90],0.5514324333454328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20406,31,1.57 [0.83-2.97],0.1657860855562167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,20438,63,1.46 [0.91-2.34],0.1199563764376948
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14086,83,0.86 [0.47-1.58],0.6357762276507657
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14238,235,0.98 [0.70-1.37],0.8876461356476356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20418,43,0.40 [0.14-1.16],0.0906643472406958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20422,47,1.50 [0.87-2.58],0.1480608397652657
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22751,82,1.07 [0.61-1.86],0.8199751845248138
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22786,109,0.60 [0.32-1.11],0.1021107664129336
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22821,82,0.49 [0.23-1.04],0.0629347760808135
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22880,70,0.41 [0.18-0.94],0.0360169016780874
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22586,58,1.43 [0.85-2.41],0.1753963845905919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22623,95,1.34 [0.87-2.05],0.1799257511832873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22072,110,1.27 [0.84-1.92],0.265380662480419
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22049,87,0.94 [0.53-1.68],0.8341010626257025
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23251,86,0.89 [0.49-1.62],0.702896907624276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,22488,526,1.15 [0.94-1.42],0.1823666846282394
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,22506,71,1.18 [0.69-2.02],0.5430452700147499
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19071,1799,0.94 [0.82-1.08],0.3723733992327215
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23251,114,1.02 [0.63-1.65],0.9356993947846716
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22082,173,0.68 [0.42-1.09],0.1094595545674233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22065,156,0.67 [0.41-1.11],0.1174327002739802
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22664,202,0.78 [0.51-1.18],0.2432098754278259
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22659,197,0.79 [0.52-1.21],0.2807108560710654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22784,481,0.78 [0.59-1.02],0.0686751686169423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22406,103,0.68 [0.37-1.24],0.2049505772001908
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,22373,70,0.94 [0.50-1.78],0.8463029536334745
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22606,303,0.83 [0.60-1.16],0.2742582011622518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22422,119,0.96 [0.59-1.56],0.8748648902924994
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11274,55,0.88 [0.43-1.80],0.7352243384755524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20898,987,1.09 [0.93-1.28],0.2937268230027328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,22554,134,1.08 [0.69-1.69],0.7493734518759567
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22571,151,1.01 [0.65-1.57],0.9570565102185602
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22571,151,1.01 [0.65-1.57],0.9570565102185602
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21665,847,1.10 [0.93-1.31],0.2713160880215759
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Asthma,17421,847,1.08 [0.91-1.28],0.3819003591786316
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17265,847,1.08 [0.91-1.28],0.3891288204561073
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17409,835,1.09 [0.92-1.30],0.3366344745818939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23164,76,1.51 [1.00-2.29],0.0518121430730178
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21878,58,1.68 [1.11-2.55],0.0140447955564179
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23226,58,1.69 [1.12-2.57],0.0130092836415226
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21871,51,1.56 [0.96-2.52],0.0731571201154295
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,21885,70,0.95 [0.50-1.81],0.879715524658216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,21978,163,0.87 [0.56-1.35],0.5267215859866462
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22452,78,0.67 [0.33-1.36],0.2670556991012679
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16251,5092,1.01 [0.92-1.11],0.8160239813815859
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22945,397,0.86 [0.65-1.14],0.2873805948792772
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23400,88,0.57 [0.29-1.13],0.1067517355209739
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,23405,80,0.46 [0.22-0.98],0.0437184063142286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,22639,91,0.98 [0.56-1.69],0.9326932391962852
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22647,99,0.78 [0.43-1.41],0.4119532537394271
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23391,96,0.67 [0.36-1.26],0.2187389512498906
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22642,94,1.01 [0.59-1.72],0.9734959639198802
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22392,61,0.56 [0.24-1.29],0.1712659093021501
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23318,39,0.77 [0.30-2.00],0.5954677565092029
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17727,185,0.99 [0.67-1.47],0.9634833705643984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19509,1967,1.02 [0.90-1.15],0.7654350837832498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,17789,247,1.18 [0.87-1.60],0.3003656758331366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18174,632,1.07 [0.88-1.32],0.4924508722749297
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17606,64,0.84 [0.41-1.72],0.631292111781812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17660,118,0.97 [0.59-1.61],0.9204475983567022
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17574,32,0.48 [0.14-1.63],0.2407072251960743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,17664,122,0.86 [0.51-1.45],0.5807898836980407
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17605,63,1.23 [0.69-2.19],0.4728766939246073
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23361,49,0.90 [0.41-1.97],0.7827058688907196
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,17652,110,1.09 [0.68-1.77],0.7173484304557591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18264,722,1.10 [0.91-1.33],0.326249334825744
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23299,130,0.49 [0.27-0.88],0.0165934836528129
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18039,497,0.99 [0.78-1.26],0.9557824178523894
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17685,143,1.13 [0.75-1.70],0.5521155770944473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23323,124,1.01 [0.64-1.60],0.970906059245704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23276,107,0.46 [0.24-0.88],0.0190413030768332
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,20991,1025,0.98 [0.83-1.17],0.8532666204528682
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20024,58,0.72 [0.33-1.60],0.420724192606466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20030,64,1.36 [0.80-2.31],0.2524857599234782
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,20052,86,1.15 [0.69-1.91],0.6006143234691854
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20788,822,0.99 [0.82-1.19],0.9048758557388896
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22517,774,1.03 [0.85-1.24],0.7930638508705554
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18594,1851,1.08 [0.96-1.22],0.2015818570581704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23159,54,0.94 [0.45-1.96],0.8661876329475642
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23388,78,0.98 [0.54-1.78],0.9572308150905046
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,21821,78,0.98 [0.54-1.78],0.9552326683080564
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21800,57,1.37 [0.80-2.35],0.2495148602919694
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23320,112,1.03 [0.64-1.67],0.9029302580460804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21855,112,1.03 [0.63-1.66],0.9122503178135776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21841,98,1.05 [0.63-1.74],0.8569889614339696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22401,658,1.04 [0.85-1.27],0.6784588418672561
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22391,648,1.05 [0.86-1.29],0.6074610612639577
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16829,86,0.76 [0.40-1.45],0.4086338983231397
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal stricture,23033,86,0.76 [0.40-1.45],0.4031501561667094
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16797,54,0.81 [0.37-1.78],0.5974622121797024
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17311,568,1.05 [0.84-1.31],0.6666740214693616
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16944,201,0.77 [0.51-1.18],0.2287498941238713
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17069,326,1.13 [0.87-1.48],0.369900606214144
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,22004,291,1.09 [0.82-1.45],0.5488956418563415
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23007,107,0.89 [0.52-1.52],0.6786478366280236
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16853,110,0.93 [0.55-1.56],0.7772091969333957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16781,38,1.14 [0.52-2.47],0.7458962732631198
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17500,757,1.17 [0.98-1.39],0.0779611686737904
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16943,200,1.28 [0.94-1.75],0.1132511409068228
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22994,94,0.83 [0.46-1.49],0.5337871715577902
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,22769,85,1.20 [0.72-1.99],0.4860114423622789
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,22729,45,1.23 [0.61-2.45],0.5652283965428093
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22096,734,0.96 [0.79-1.18],0.7209970838145963
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,21973,611,0.84 [0.67-1.06],0.1462491506709813
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,21474,112,1.42 [0.98-2.06],0.0623799007219522
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21417,55,0.61 [0.26-1.44],0.256341511427902
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21412,50,0.48 [0.18-1.26],0.1366383632921312
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23301,50,0.48 [0.18-1.25],0.1331005897850413
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22270,254,1.38 [1.07-1.79],0.0145258771917007
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22103,87,1.28 [0.81-2.03],0.2922223621293177
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,22091,75,1.29 [0.78-2.11],0.3215497659148901
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22049,33,1.54 [0.82-2.91],0.1805676842866608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22155,139,1.45 [1.03-2.03],0.0309005993747599
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,22147,131,1.39 [0.97-1.99],0.0763883417031827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20756,1379,0.99 [0.85-1.14],0.8445828542861962
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23040,100,0.86 [0.49-1.51],0.6062769649577614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23054,389,0.94 [0.72-1.24],0.673143365153319
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22106,587,0.98 [0.79-1.22],0.8866366503279131
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22730,278,1.25 [0.95-1.64],0.1083444167748373
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22516,64,1.29 [0.73-2.26],0.3789426604706326
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22629,177,1.19 [0.84-1.70],0.3232518967943696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23180,77,1.47 [0.94-2.30],0.0900996678174038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23158,55,1.57 [0.95-2.58],0.0776784485398706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23145,42,1.67 [0.98-2.83],0.0592959774939862
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23217,50,0.51 [0.20-1.32],0.1655429892783162
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23214,47,0.55 [0.21-1.43],0.2225811788728835
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22715,50,0.24 [0.09-0.67],0.0064391905825647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22969,304,0.94 [0.69-1.28],0.6753740946924369
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21603,84,0.98 [0.55-1.74],0.9389781429453052
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21648,129,0.87 [0.53-1.42],0.5821207631306263
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21613,94,0.75 [0.40-1.38],0.3529674687249593
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21736,217,0.93 [0.65-1.34],0.6912679806086791
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21715,196,0.92 [0.63-1.35],0.6837295464426405
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16511,3754,0.91 [0.82-1.01],0.0685943281880046
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17990,2155,0.90 [0.79-1.02],0.0977612616644638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21036,1134,1.09 [0.93-1.26],0.2914662878586462
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16026,191,0.96 [0.66-1.41],0.8512177310310518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16278,443,0.92 [0.71-1.20],0.5421173482842983
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22954,183,0.98 [0.67-1.45],0.937576348677304
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22968,168,1.00 [0.67-1.49],0.9937016009438032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16872,1037,0.91 [0.76-1.09],0.2999463965837613
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19168,1037,0.92 [0.77-1.10],0.3875819305626186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15846,11,1.43 [0.40-5.18],0.583845377453307
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23277,11,1.60 [0.47-5.41],0.4489417771520998
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16061,226,0.88 [0.60-1.28],0.4923881896492186
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15910,75,0.96 [0.52-1.75],0.8836843283362572
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16101,266,1.05 [0.77-1.44],0.741802095110093
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23259,138,0.97 [0.62-1.52],0.9090750277718296
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16236,401,0.89 [0.67-1.19],0.437454701848594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16237,402,0.80 [0.59-1.07],0.1362169502286493
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17036,1201,0.87 [0.73-1.03],0.0953175541878014
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),15934,99,1.10 [0.68-1.80],0.6940155568560173
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16190,355,0.91 [0.68-1.21],0.5143015537483991
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15903,68,0.53 [0.24-1.19],0.1228051049876912
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),15923,88,1.04 [0.61-1.78],0.8755471880699193
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16148,313,0.91 [0.66-1.23],0.529258914887583
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16101,266,0.94 [0.67-1.30],0.7023310124457011
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17428,253,0.85 [0.60-1.20],0.3551601650611622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22717,207,1.02 [0.72-1.45],0.9131462670570516
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22592,82,0.89 [0.49-1.63],0.7150422713005655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20068,73,0.58 [0.28-1.24],0.1601178439015476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20265,270,0.68 [0.47-1.00],0.0486485278390725
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20877,882,0.83 [0.68-1.01],0.0611534042868108
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20182,187,0.66 [0.42-1.05],0.0796080854548853
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20064,69,0.63 [0.29-1.35],0.2344347001914264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20699,704,0.85 [0.69-1.06],0.1439440432802448
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20037,42,1.21 [0.60-2.42],0.5994261604288118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20203,208,0.76 [0.51-1.15],0.1951175850916874
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20084,89,0.78 [0.42-1.45],0.4353132949754595
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20069,74,1.01 [0.55-1.84],0.9851976229833972
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20124,129,0.91 [0.56-1.46],0.6898551653772418
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20063,68,1.15 [0.66-2.02],0.619331061497935
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20304,309,0.67 [0.47-0.96],0.0277524928770096
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20232,330,1.12 [0.86-1.47],0.3979648022919997
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19963,61,1.56 [0.99-2.47],0.0565114145419821
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19995,93,1.05 [0.62-1.77],0.8656277350759957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20023,121,1.02 [0.65-1.62],0.919903404298656
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19939,37,1.59 [0.89-2.85],0.1176050694052918
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19948,46,0.89 [0.40-2.01],0.778813736319386
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19937,35,0.97 [0.40-2.37],0.9480023152451325
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20133,231,0.88 [0.61-1.27],0.499567401353069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19953,51,1.14 [0.60-2.18],0.681155057217895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19958,56,0.67 [0.29-1.55],0.347655374664222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20015,113,0.82 [0.47-1.41],0.4688578439058496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19973,71,1.21 [0.70-2.07],0.4912114192740824
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20368,466,1.15 [0.92-1.44],0.2272887281243446
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20067,165,1.23 [0.87-1.75],0.2417534088535627
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20158,256,1.08 [0.79-1.49],0.6197421682300106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21119,208,0.83 [0.56-1.23],0.353656069006666
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21317,406,0.94 [0.72-1.23],0.6691544383255132
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20944,33,1.50 [0.81-2.81],0.1999014908854701
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20960,49,0.68 [0.28-1.63],0.3854039721281199
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21001,90,0.56 [0.28-1.12],0.1018021860956635
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19227,5256,1.01 [0.93-1.10],0.8580103892113526
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21459,149,1.48 [1.09-2.01],0.0125858014996322
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21345,35,1.91 [1.21-3.01],0.0053273410044682
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21626,25,0.82 [0.25-2.63],0.7363274550933576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21630,29,2.19 [1.45-3.33],0.0002176786654092
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21631,30,0.98 [0.38-2.58],0.9741596169704048
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23228,104,1.23 [0.80-1.89],0.3397180437029549
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23142,50,0.81 [0.36-1.84],0.6127981137865981
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23202,78,1.13 [0.66-1.92],0.6573834901019189
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,1.54 [0.84-2.81],0.1640658290491554
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21577,1076,0.93 [0.78-1.10],0.3715881719192311
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20607,106,1.31 [0.87-1.97],0.1978047353060397
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20574,73,0.85 [0.44-1.64],0.6229185479469748
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20641,140,1.05 [0.69-1.61],0.8044249399465648
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20580,79,0.53 [0.25-1.13],0.0990248022080181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21353,852,0.99 [0.82-1.18],0.8828428805882657
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23177,417,1.06 [0.83-1.35],0.6675021910690335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22888,128,1.44 [1.02-2.03],0.0381010686576153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22902,142,1.18 [0.81-1.73],0.3905525779297079
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22864,104,0.66 [0.36-1.22],0.1821809007931486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23118,479,0.95 [0.74-1.21],0.6795211437937114
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22754,115,1.24 [0.82-1.86],0.3049818369559801
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22853,214,1.06 [0.75-1.49],0.740420211406791
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21385,3943,1.01 [0.92-1.11],0.7869232904665762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17743,301,1.01 [0.75-1.37],0.9422583375699508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17527,85,1.01 [0.57-1.78],0.9805744295820442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17578,136,1.07 [0.70-1.65],0.7515111578548117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18127,685,0.93 [0.75-1.15],0.5160685656151713
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17785,343,0.89 [0.66-1.20],0.4535845520445095
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18259,817,1.03 [0.86-1.23],0.7733630312756711
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17714,272,0.71 [0.49-1.03],0.0711251503057935
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17820,378,0.89 [0.67-1.19],0.4453361229023029
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17527,85,nan [nan-nan],
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17606,164,1.14 [0.78-1.67],0.5019414501177422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23403,228,1.18 [0.87-1.62],0.2884965286198659
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23412,216,1.19 [0.87-1.63],0.2853493886677483
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23432,117,1.13 [0.72-1.77],0.5858636765727914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23424,129,1.22 [0.81-1.84],0.332027022127256
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17567,125,1.07 [0.68-1.68],0.7803675469339291
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17545,103,0.65 [0.35-1.21],0.1747039122289276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17563,121,0.75 [0.44-1.30],0.3073066441270067
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23345,396,1.13 [0.89-1.44],0.3270634144520474
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18597,1155,1.14 [0.98-1.32],0.0946526149532419
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18197,755,1.15 [0.96-1.38],0.1198626288418227
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23421,172,1.05 [0.72-1.55],0.7890223151699762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17838,396,1.30 [1.04-1.62],0.022442224549974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17710,268,0.91 [0.65-1.28],0.5926575975355489
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18223,781,1.01 [0.84-1.23],0.8892303861431937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female infertility,17529,87,0.73 [0.39-1.38],0.3311203618694509
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17522,80,0.71 [0.37-1.38],0.3117116540803512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23429,723,1.03 [0.83-1.26],0.8105757848920587
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23435,988,1.00 [0.83-1.21],0.9965553001616696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23430,384,0.79 [0.59-1.08],0.1354642742197793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23155,109,1.10 [0.68-1.76],0.7015934756384037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23202,156,0.51 [0.30-0.87],0.0136502498459943
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23180,134,0.86 [0.52-1.41],0.5477851528844431
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23445,140,1.08 [0.72-1.64],0.6978258831032671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23447,139,1.07 [0.71-1.63],0.7371904474938626
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23444,355,1.02 [0.77-1.35],0.8882923928213056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23193,104,0.83 [0.47-1.45],0.5061314022211558
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23289,200,1.10 [0.78-1.56],0.5877392184249757
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22829,123,0.66 [0.37-1.17],0.1546647071388622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22874,168,1.07 [0.72-1.59],0.7362337393275872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22908,202,1.32 [0.97-1.80],0.0746758448786297
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22831,125,0.93 [0.56-1.52],0.7607497874705375
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22821,115,1.15 [0.72-1.82],0.565550993317895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22825,119,1.04 [0.65-1.66],0.8748017786679121
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22638,191,0.90 [0.59-1.37],0.6350017786516724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22809,362,1.01 [0.76-1.35],0.944866025193264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22997,550,1.14 [0.91-1.43],0.2497066115414389
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23449,143,1.10 [0.73-1.66],0.6392811071269354
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22248,110,1.25 [0.81-1.94],0.3088611224267933
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22528,81,1.12 [0.64-1.94],0.6901949977688644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23455,277,0.76 [0.53-1.09],0.1368128506110555
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23393,215,0.93 [0.64-1.35],0.7048951464590203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23444,208,0.76 [0.50-1.15],0.1913584685139633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23434,198,0.79 [0.53-1.20],0.2733693454946398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23197,42,1.26 [0.64-2.46],0.5067865678384762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21008,534,0.91 [0.71-1.15],0.4247687199877302
